NasdaqCM - Delayed Quote • USD
Journey Medical Corporation (DERM)
At close: April 26 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.23 | -0.19 | -0.74 | -0.2 |
| Low Estimate | -0.26 | -0.23 | -0.83 | -0.6 |
| High Estimate | -0.21 | -0.16 | -0.65 | 0.2 |
| Year Ago EPS | -0.57 | -0.46 | -0.21 | -0.74 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 14.1M | 14.52M | 58.01M | 82.04M |
| Low Estimate | 13.29M | 14.4M | 57.98M | 64.03M |
| High Estimate | 14.91M | 14.65M | 58.04M | 100.05M |
| Year Ago Sales | 12.21M | 14.81M | 79.18M | 58.01M |
| Sales Growth (year/est) | 15.50% | -2.00% | -26.70% | 41.40% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.45 | -0.33 | -0.15 | -0.08 |
| EPS Actual | -0.57 | -0.46 | 0.8 | -0.12 |
| Difference | -0.12 | -0.13 | 0.95 | -0.04 |
| Surprise % | -26.70% | -39.40% | 633.30% | -50.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.23 | -0.19 | -0.74 | -0.2 |
| 7 Days Ago | -0.23 | -0.19 | -0.74 | -0.2 |
| 30 Days Ago | -0.17 | -0.12 | -0.49 | 0.03 |
| 60 Days Ago | -0.15 | -0.08 | -0.31 | 0.04 |
| 90 Days Ago | -0.19 | -0.09 | -0.34 | -0.06 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | DERM | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 59.60% | -- | -- | 5.40% |
| Next Qtr. | 58.70% | -- | -- | 10.90% |
| Current Year | -252.40% | -- | -- | 4.50% |
| Next Year | 73.00% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Alliance Global Partners: Buy | 2/16/2024 |
| Reiterates | B. Riley Securities: Buy to Buy | 9/7/2023 |
| Maintains | B. Riley Securities: Buy to Buy | 7/12/2023 |
| Maintains | B. Riley Securities: Buy to Buy | 5/23/2023 |
| Reiterates | B. Riley Securities: Buy | 3/30/2023 |
| Initiated | Cantor Fitzgerald: Overweight | 2/25/2022 |
Related Tickers
SBFMW Sunshine Biopharma, Inc.
0.0700
+39.72%
BFRI Biofrontera Inc.
1.5900
-7.02%
IRWD Ironwood Pharmaceuticals, Inc.
7.82
-3.22%
IXHL Incannex Healthcare Inc.
2.2200
-3.48%
AQST Aquestive Therapeutics, Inc.
4.0700
+3.56%
CPH.TO Cipher Pharmaceuticals Inc.
8.50
0.00%
SCYX SCYNEXIS, Inc.
1.5400
+4.76%
EGRX Eagle Pharmaceuticals, Inc.
4.1600
-1.89%
ESPR Esperion Therapeutics, Inc.
1.9000
-4.52%
GRYN Green Hygienics Holdings Inc.
0.0006
0.00%